Influence of modulation restriction in inverse optimization with HIPO of prostate implants on plan quality: Analysis using dosimetric and radiobiological indices

IFMBE Proceedings

Volumn 25, Issue 1, 2009, Pages 283-286

  Baltas, D ^a,b   Katsilieri, Z ^a   Kefala, V ^a   Papaioannou, S ^a   Karabis, A ^c   Mavroidis, P ^d,e   Zamboglou, N ^a  

^a Klinikum Offenbach GmbH   (Germany)

^b UNIVERSITY OF ATHENS   (Greece)

^c Pi Medical Ltd   (Greece)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

HIPO; Inverse optimization; Modulation restriction; Prostate HDR brachytherapy

Indexed keywords

BIOMEDICAL ENGINEERING; DOSIMETRY; MEDICAL PHYSICS; MODULATION; ONCOLOGY; RADIOTHERAPY; UROLOGY;

HDR BRACHYTHERAPY; HIPO; INVERSE OPTIMIZATION; INVERSE TREATMENT; OPTIMIZATION ALGORITHMS; PROSTATE IMPLANTS; STATE OF THE ART; VOLUMES OF INTERESTS;

QUALITY CONTROL;

EID: 77950434841     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-642-03474-9_81     Document Type: Conference Paper

References (11)

1. Lahanas M,Baltas D,Giannouli S (2003) Global convergence analysis of fast multiobjective gradient-based dose optimization algorithms for high-dose-rate brachytherapy. Phys Med Biol 48:599-617
2. Karabis A, Giannouli S, Baltas D (2005) HIPO: A hybrid inverse treatment planning optimization algorithm in HDR Brachytherapy. Radiother Oncol, 76 Supplement 2, 29
3. Baltas D, Kolotas C, Geramani K, Mould RF, Ioannidis G, Kekchidi M and Zampoglou N (1998) A Conformal Index (COIN) to evaluate implant quality and dose specification in Brachytherapy. Int J Radiat Oncol Biol Phys 40:512-524
4. Milickovic N, Lahanas M, Papagiannopoulou M, Zampoglou N and Baltas D (2002) Multiobjective anatomy-based dose optimization for HDR- brachytherapy with constraint free deterministic algorithms. Phys Med Biol 47:2263-2280
5. Meertens H, Borger J, Steggerda M, Blom A, Evaluation and Optimization of interstitial Brachytherapy dose distributions. Brachytherapy from Radium to Optimization.edited by Mould RF, Battermann JJ, Martinez AA, Speiser BL, 301-306
6. Niemerko A (1997) Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med. Phys. 24:103-110
7. Li A X, Wang JZ, Jursinic P A, Lawton C A, Wang D (2005) Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer. Int J Radiat Oncol Biol Phys, 61:1251-1257
8. 100 correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer. Int J Radiat Oncol Biol Phys, 69, 3, S381-S382
9. Wu Q, Djajaputra D, Liu HH., Dong L., Mohan R., Wu Y. (2005) Dose sculpting with generalized equivalent uniform dose. Med Phys 32: 1387-1396
10. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R.(2002) Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys. 52:224-235
11. Semenenko VA.,Reitz B, Day E, Qi XS,Miften M., Li. X A, (2008) Evaluation of a commercial biologically based IMRT treatment planning system. Med Phys 35:5851-5860